| For: | Uno K, Suginoshita Y, Kakimi K, Moriyasu F, Hirosaki M, Shirakawa T, Kishida T. Impairment of IFN-α production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma. World J Gastroenterol 2005; 11(46): 7330-7334 [PMID: 16437637 DOI: 10.3748/wjg.v11.i46.7330] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i46/7330.htm |
| Number | Citing Articles |
| 1 |
Le H. Song, Nguyen L. Toan, Nguyen T. Xuan, Anne-Catrin Uhlemann, Angelica B.W. Boldt, Dinh N. Duy, Vu Q. Binh, Peter G. Kremsner, Jürgen F.J. Kun. A promoter polymorphism in the interferon α-2 gene is associated with the clinical presentation of hepatitis B. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2006; 601(1-2): 137 doi: 10.1016/j.mrfmmm.2006.06.011
|
| 2 |
Kazuko Uno, Katsumi Yagi, Masayo Yoshimori, Mari Tanigawa, Toshikazu Yoshikawa, Setsuya Fujita. IFN production ability and healthy ageing: mixed model analysis of a 24 year longitudinal study in Japan. BMJ Open 2013; 3(1): e002113 doi: 10.1136/bmjopen-2012-002113
|
| 3 |
Kazuko Uno, Eri Muso, Toshiko Ito-Ihara, Tomomi Endo, Yuko Yasuda, Katusmi Yagi, Kazuo Suzuki. Impaired HVJ-stimulated Interferon producing capacity in MPO-ANCA-associated vasculitis with rapidly progressive glomerulonephritis lead to susceptibility to infection. Cytokine 2020; 136: 155221 doi: 10.1016/j.cyto.2020.155221
|
